One prominent context exists immediately after myocardial infarction, when the survival of cardiomyocytes in the myocardium is known to be severely compromised and also MEF2 activity is repressed by hyperactivation of β-adrenergic signaling and subsequent PKA-mediated phosphorylation. The gene discussed is MEF2A; the disease is myocardial infarction.